Isopimpinellin was documented to inhibit chemically induced skin tumors in mice by blocking the formation of DNA adducts and impairing the activation of CYP1 and CYP2B involved in the metabolism of carcinogens [62,63,64]. The gene discussed is CYP1A1; the disease is skin neoplasm.